₹60.83
▼ -0.41 -0.67%
17 Jul 2026
NSE Listed · Pharmaceuticals
Morepen Lab. Ltd. (MOREPENLAB)
Volume: 45,67,550Avg Vol 1W: 53,68,810Avg Vol 1M: 58,26,56852W Range:₹33.05₹65.12
Key Ratios
Checked just nowMarket Cap₹3,333 Cr
Current Price₹60.83
Previous Close₹61.24
High / Low (52w)₹65.12 / ₹33.05
Volume45,67,550
Avg Vol (1W)53,68,810
Avg Vol (1M)58,26,568
Stock P/E217.25
Book Value₹22.75
Dividend Yield0.4%
ROE5.96%
ROA4.94%
Revenue (TTM)—
Revenue Growth7.17%
Profit Margin5.25%
Total Debt₹26 Cr
Shares Outstanding55 Cr
Face Value₹2
EPS (TTM)₹0.28
P/B2.67
Debt / Equity0.17
50 DMA₹56.28
200 DMA₹45.17
Day change-0.67%
Price Chart
₹60.83▲ 38.22% · 1Y
2025-11-212026-07-16
20-day avg volume: 56.6L shares
Pros
- Company is almost debt-free.
- Net profit is growing year over year.
Cons
- Stock trades at a high P/E of 217.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹455 Cr | ₹438 Cr | ₹453 Cr | ₹466 Cr | ₹425 Cr | ₹412 Cr | ₹484 Cr | ₹485 Cr |
| EBITDA | ₹49 Cr | ₹47 Cr | ₹37 Cr | ₹30 Cr | ₹20 Cr | ₹24 Cr | ₹40 Cr | ₹27 Cr |
| Net Profit | ₹36 Cr | ₹35 Cr | ₹27 Cr | ₹20 Cr | ₹11 Cr | ₹41 Cr | ₹28 Cr | ₹16 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹610 Cr | ₹772 Cr | ₹863 Cr | ₹1,200 Cr | ₹1,557 Cr | ₹1,424 Cr | ₹1,704 Cr | ₹1,830 Cr |
| EBITDA | ₹34 Cr | ₹31 Cr | ₹41 Cr | ₹100 Cr | ₹119 Cr | ₹58 Cr | ₹139 Cr | ₹163 Cr |
| Net Profit | ₹30 Cr | ₹29 Cr | ₹34 Cr | ₹97 Cr | ₹102 Cr | ₹39 Cr | ₹96 Cr | ₹118 Cr |
| EPS | 0.66 | 0.64 | 0.75 | 2.15 | 1.96 | 0.77 | 1.88 | 2.2 |
Balance Sheet
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹586 Cr | ₹615 Cr | ₹663 Cr | ₹858 Cr | ₹1,070 Cr | ₹1,110 Cr | ₹1,293 Cr | ₹1,778 Cr |
| Total Liabilities | ₹360 Cr | ₹363 Cr | ₹380 Cr | ₹434 Cr | ₹492 Cr | ₹358 Cr | ₹446 Cr | ₹591 Cr |
| Equity | ₹225 Cr | ₹253 Cr | ₹284 Cr | ₹424 Cr | ₹578 Cr | ₹752 Cr | ₹847 Cr | ₹1,187 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹63 Cr | ₹18 Cr | ₹17 Cr | ₹52 Cr | ₹-35 Cr | ₹-75 Cr | ₹111 Cr | ₹69 Cr |
| Investing | ₹-27 Cr | ₹-13 Cr | ₹-12 Cr | ₹-70 Cr | ₹-32 Cr | ₹-47 Cr | ₹-83 Cr | ₹-322 Cr |
| Financing | ₹-38 Cr | ₹0 Cr | ₹5 Cr | ₹47 Cr | ₹66 Cr | ₹144 Cr | ₹5 Cr | ₹300 Cr |
| Free Cash Flow | ₹63 Cr | ₹18 Cr | ₹17 Cr | ₹52 Cr | ₹-35 Cr | ₹-75 Cr | ₹111 Cr | ₹69 Cr |
Shareholding
Promoter 35.65% Institutions 2.74% Public 61.6%
Efficiency & Working Capital
ROCE7.6%
Interest Coverage19.6
Dividend Payout—
Debtor Days65 d
Inventory Days60 d
Payable Days73 d
Cash Conversion Cycle53 d
Working Capital Days126 d
Shareholding Details
As of 2026-06-30
Promoter35.7%
FII1.5%
DII1.3%
Institutions2.7%
Public61.6%
Promoter Pledge0%
No. of Shareholders4,34,912
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Mar 2024 | Jun 2024 | Aug 2024 | Aug 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 38.2% | 38.2% | 35.7% | 35.7% | 35.7% | 35.7% | 35.7% | 35.7% | 35.7% | 35.7% | 35.7% | 35.7% |
| FIIs | 1.9% | 1.7% | 7.7% | 7.7% | 2.1% | 2.2% | 1.9% | 1.7% | 1.6% | 1.6% | 1.6% | 1.5% |
| DIIs | 2.2% | 2.1% | 2.9% | 2.9% | 1.7% | 1.6% | 1.7% | 1.5% | 1.5% | 1.3% | 1.3% | 1.3% |
| Public | 57.8% | 58% | 53.7% | 53.7% | 60.6% | 60.5% | 60.7% | 61.1% | 61.2% | 61.5% | 61.5% | 61.6% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 3,36,019 | 3,48,766 | 3,52,839 | 3,52,839 | 4,30,929 | 4,48,361 | 4,68,860 | 4,61,180 | 4,61,853 | 4,53,137 | 4,47,286 | 4,34,912 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Pinfold Overseas Limited | Public Shareholding | 7% | 3.85 Cr |
| Scope Credits And Financial Services Pvt. Ltd. | Shareholding of Promoter and Promoter Group | 2.8% | 1.56 Cr |
| Concept Credits And Consultants Pvt. Ltd. | Shareholding of Promoter and Promoter Group | 2.8% | 1.53 Cr |
| Brook Investments And Financial Services Pvt. Ltd | Shareholding of Promoter and Promoter Group | 2.8% | 1.52 Cr |
| Solitary Investments And Financial Services Pvt. Ltd. | Shareholding of Promoter and Promoter Group | 2.8% | 1.51 Cr |
| Solace Investments And Financial Services Pvt. Ltd. | Shareholding of Promoter and Promoter Group | 2.8% | 1.51 Cr |
| Mid Med Financial Services And Investments Pvt. Ltd. | Shareholding of Promoter and Promoter Group | 2.7% | 1.50 Cr |
| React Investments And Financial Services Pvt. Ltd. | Shareholding of Promoter and Promoter Group | 2.7% | 1.49 Cr |
| Epitome Holdings Pvt.ltd. | Shareholding of Promoter and Promoter Group | 2.7% | 1.45 Cr |
| Seed Securities And Services Pvt. Ltd. | Shareholding of Promoter and Promoter Group | 2.6% | 1.43 Cr |
| Square Investments And Financial Services Pvt. Ltd. | Shareholding of Promoter and Promoter Group | 2.6% | 1.41 Cr |
| Morepen Laboratories Limited | Public Shareholding | 1% | 55,77,144 |
| Sushil Suri | Shareholding of Promoter and Promoter Group | 1% | 55,01,510 |
| Anju Suri | Shareholding of Promoter and Promoter Group | 1% | 51,86,369 |
| Liquid Holdings Pvt. Ltd. | Shareholding of Promoter and Promoter Group | 0.9% | 50,03,000 |
| Sonia Pankaj Bajaj | Shareholding of Promoter and Promoter Group | 0.7% | 36,79,718 |
| Sanjay Suri | Shareholding of Promoter and Promoter Group | 0.6% | 34,17,240 |
| Sunita Suri | Shareholding of Promoter and Promoter Group | 0.6% | 31,92,240 |
| Varun Suri | Shareholding of Promoter and Promoter Group | 0.6% | 30,52,357 |
| Mamta Suri | Shareholding of Promoter and Promoter Group | 0.6% | 30,04,000 |
| Sanjay Suri (sanjay Suri Sons Huf) | Shareholding of Promoter and Promoter Group | 0.4% | 21,00,000 |
| Shalu Suri | Shareholding of Promoter and Promoter Group | 0.4% | 20,52,250 |
| Anubhav Suri (arun Suri Sons Huf) | Shareholding of Promoter and Promoter Group | 0.3% | 15,00,000 |
| Sushil Suri (sushil Suri Sons Huf) | Shareholding of Promoter and Promoter Group | 0.2% | 12,01,560 |
| Gulfy Malhotra | Shareholding of Promoter and Promoter Group | 0.2% | 11,50,000 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Late Kanta Suri | 0 | 0% | 2026-06-30 |
| Rajas Suri (kb Suri Sons Huf) | 0 | 0% | 2026-06-30 |
| Sanjay Suri (sanjay Suri Sons Huf) | 0 | 0% | 2026-06-30 |
| Praduman Lal Suri Huf | 0 | 0% | 2026-06-30 |
| Sushil Suri (sushil Suri Sons Huf) | 0 | 0% | 2026-06-30 |
| Anubhav Suri (arun Suri Sons Huf) | 0 | 0% | 2026-06-30 |
| Mamta Suri | 0 | 0% | 2026-06-30 |
| Sonia Pankaj Bajaj | 0 | 0% | 2026-06-30 |
| Sanjay Suri | 0 | 0% | 2026-06-30 |
| Late P.l. Suri | 0 | 0% | 2026-06-30 |
| Anju Suri | 0 | 0% | 2026-06-30 |
| Sushil Suri | 0 | 0% | 2026-06-30 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Sushil Suri | Chairman / Executive Director / M D / Promoter | 2025 |
| Sanjay Suri | WTD & Executive Director | 2025 |
| Praveen Kumar Dutt | Independent Non Exe. Director | 2025 |
| Ranjit Khattar | Independent Non Exe. Director | 2025 |
| Savita | Independent Non Exe. Director | 2025 |
| Sharad Jain | Independent Non Exe. Director | 2025 |
| Vipul Kumar Srivastava | Company Secretary | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Pharmaceuticals | ₹0 Cr | — |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹2 | 200 | 110 | 110 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| dividend | 2025-08-29 | ₹0.2 (10%) | Final |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 171 | 0 | 0 | 7 | 0 | 195 |
| 2025 | 165 | 0 | 0 | 1 | 0 | 172 |
| 2025 | 6 | 0 | 0 | 7 | 0 | 22 |
Insider / Designated-Person Trades
11 recent disclosure(s)
Liquid Holdings Private LimitedAcquisition · 50,00,000
React Investments and Financial Services Private LimitedAcquisition · 35,00,000
Mid-Med Financial Services and Investments Private LimitedAcquisition · 35,00,000
Square Investments and Financial Services Private LimitedAcquisition · 35,00,000
Solitary Investments and Financial Services Private LimitedAcquisition · 35,00,000
Solace Investments and Financial Services Private LimitedAcquisition · 35,00,000
Company Information
🌐 www.morepen.com ↗
📍 Morepen Village, Nalagarh Road Near Baddi, Solan, Himachal Pradesh, 173205
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Monarch Networth Cap Ltd.Moneyboxx Finance LimitedMonolithisch India Ltd.Mono Pharmacare LimitedMonte Carlo Fashions Ltd.Morarjee Textiles LimitedMos Utility LimitedMoschip Technologies Ltd.Samvardhana Motherson IntMotilal Oswal Fin Ltd.Motisons Jewellers Ltd.Motor & General Finance LimitedAll “M” stocks →
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search